GSK wins jury verdict in Illinois ranitidine cancer case

GSK plc has welcomed today’s jury verdict in the Joiner case in Illinois state court finding in GSK’s favour.

· Jury in Joiner case in Illinois state court finds GSK not liable for plaintiff’s colorectal cancer

· Verdict is consistent with the scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer

· GSK will continue to vigorously defend itself against all other claims

This outcome is consistent with the scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, supported by 16 epidemiological studies looking at human data regarding the use of ranitidine. GSK will continue to vigorously defend itself against all other claims.

Prior to this verdict, the court rejected the Plaintiff’s ability to request punitive damages.

Share on:

Written by: Amilia Stone

Latest Company News

GSK wins FDA approval for hepatitis B treatment Hibsago

October 21, 2026

GSK has received FDA approval for Hibsago (bepirovirsen), a new chronic hepatitis B treatment that achieved a 19% functional cure rate in Phase III trials after six months of treatment.

GSK reports positive global results for lung cancer drug candidate

October 19, 2026

GSK reports first global data for investigational antibody-drug conjugate risvutatug rezetecan, showing a confirmed objective response rate of 61% at the 8 mg/kg dose in patients with relapsed extensive-stage small cell lung cancer.

GSK to acquire Chimagen Trispecific T-cell engager for multiple myeloma

September 15, 2026

GSK has agreed to acquire global rights to Chimagen Biosciences’ trispecific T-cell engager for multiple myeloma in a deal worth up to $750 million. The programme is expected to enter Phase I trials in 2027.

GSK’s Shingrix prefilled syringe approved in Japan

September 10, 2026

Japan’s health ministry has approved a ready-to-use prefilled syringe presentation of GSK’s Shingrix shingles vaccine, simplifying preparation and administration for healthcare professionals.